Private equity has long shown interest in ASCs, but some industry leaders believe that heightened scrutiny of PE’s healthcare investments could dampen this trend.
Private Equity
Becker's connected with Nilesh Dave, MD, vice president of clinical effectiveness and chief medical officer at Arlington-based Texas Health Resources to discuss the role of profit-driven companies in healthcare.
Private equity firms have solidified their place in healthcare over the last decade. 2012 saw just 75 PE transactions in healthcare –– in 2021, that number reached 484.
VC funds are booming –– and their interest is turning increasingly toward healthcare.
Private equity interest in ASCs is growing. Here are 10 things to know about PE and ASCs:
As the healthcare market becomes increasingly competitive, whether due to staffing competition, rising labor and supply costs or economic pressures, many practices are partnering with larger entities, including private equity firms.
In June, U.S. Senators Elizabeth Warren and Ed Markey of Massachusetts introduced legislation targeting "corporate greed and private equity abuse" in the healthcare industry.
Lawmakers in California are considering a bill that would create additional oversight for private equity companies attempting to purchase healthcare facilities, including ASCs.
CVS Health is looking for private equity firms to help fund Oak Street Health's expansion and addition of new clinics, Bloomberg reported May 23.
Private equity's interest in healthcare has boomed in recent years, and it remained a formidable force in the industry in 2023.
